Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Functional Magnetic Resonance Imaging of the Lung to Detect Regional Reversibility and Progression in Interstitial Lung Disease

NCT07300696 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.

NCT NCT07300696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07300696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Functional Magnetic Resonance Imaging of the Lung to Detect Regional Reversibility and Progression in Interstitial Lung Disease
Lead sponsor
University Hospital Heidelberg
Phase
Not applicable
Overall status
Recruiting
Start date
November 20, 2025
Completion date
July 31, 2027
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung diseases (ild)